Zealand_Pharma discloses insider share transactions
Analysis based on 7 articles · First reported May 29, 2026 · Last updated Jun 10, 2026
The market impact is generally neutral as these are routine disclosures of insider transactions. Investors may monitor these transactions for insights into insider confidence in Zealand Pharma's future performance, which could subtly influence stock price.
Zealand Pharma, a biotechnology company, has issued multiple company announcements on May 29, 2026, and June 10, 2026, regarding transactions in its shares and/or related securities. These transactions were conducted by persons discharging managerial responsibilities and/or their closely associated persons. The company received information on these transactions and subsequently published the details, as required by regulatory guidelines. Zealand Pharma is headquartered in Copenhagen, Denmark, with a U.S. presence in Boston, Massachusetts, and its shares are traded on Nasdaq-100.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard